Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Oct 9, 2026
424B3 Oct 9, 2026 424B3
S-4/A Oct 8, 2026 S-4/A
S-4/A Oct 5, 2026 S-4/A
S-4/A Sep 21, 2026 S-4/A
S-4/A Sep 3, 2026 S-4A
425 Sep 3, 2026 425
8-K Sep 3, 2026 8-K
SCHEDULE 13G/A Aug 14, 2026
10-Q Aug 10, 2026 10-Q
425 Jul 22, 2026 425
S-4 Jul 21, 2026 S-4
SCHEDULE 13D Jul 2, 2026
4 Jun 29, 2026
SCHEDULE 13G Jun 25, 2026
425 Jun 24, 2026 425
425 Jun 24, 2026 425
8-K Jun 24, 2026 FORM 8-K
8-K May 27, 2026 8-K
8-K May 26, 2026 FORM 8-K
4 May 21, 2026
4 May 21, 2026
4 May 21, 2026
4 May 21, 2026
4 May 21, 2026
← Newer Page 1 of 18 · 442 filings Older →